FDA gives COVID drug with Memphis ties fast-track to emergency use
The drug was created as an anti-cancer agent in collaboration with GTx, a former Memphis pharmaceutical firm.
Topics
sabizabulin Veru Inc Mitchell Steiner coronavirus COVID-19 GTx ARDSJane Roberts
Jane Roberts has reported in Memphis for more than 20 years. As a senior member of The Daily Memphian staff, she was assigned to the medical beat during the COVID-19 pandemic. She also has done in-depth work on other medical issues facing our community, including shortages of specialists in local hospitals. She covered K-12 education here for years and later the region’s transportation sector, including Memphis International Airport and FedEx Corp.
Comments
Want to comment on our stories? If you’re a subscriber, scroll down to the comments. If you’re not a subscriber, only paid subscribers can add their thoughts, so subscribe now. Our commenting policy can be viewed here.